Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Pacira BioSciences, Inc. - Common Stock (NQ:PCRX)

23.09 +0.42 (+1.85%)

Streaming Delayed Price Updated: 1:06 PM EDT, Jun 5, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	148,901
Open	22.92
Bid (Size)	23.06 (300)
Ask (Size)	23.17 (200)
Prev. Close	22.67
Today's Range	22.71 - 23.37
52wk Range	18.80 - 27.64
Shares Outstanding	44,454,792
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Pacira Biosciences Inc (NASDAQ:PCRX) Emerges as a Deep Value Opportunity with Strong Financial Health ↗

June 02, 2026

Via Chartmill

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees

May 28, 2026

From Pacira BioSciences

Via GlobeNewswire

Performance

YTD	-5.6%	-5.6%
1 Month	-6.9%	-6.9%
3 Month	+1.0%	+1.0%
6 Month	-3.7%	-3.7%
1 Year	-14.4%	-14.4%

More News

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees

May 27, 2026

From Pacira BioSciences

Via GlobeNewswire

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

May 27, 2026

From Biotech Insider

Via GlobeNewswire

PACIRA BIOSCIENCES INC (NASDAQ:PCRX): A Value Stock Candidate with Margin of Safety ↗

May 05, 2026

Via Chartmill

Pacira Biosciences (NASDAQ:PCRX) Q1 2026 Results Beat Estimates as Key Pipeline Catalysts Near ↗

April 30, 2026

Via Chartmill

Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty

May 27, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy

May 26, 2026

From Pacira BioSciences

Via GlobeNewswire

A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching

May 22, 2026

From World Street Intelligence

Via GlobeNewswire

Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders

May 20, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences

May 13, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees

May 12, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 08, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences Mails Letter to Stockholders

May 05, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences' CFO Sold 12,941 Shares for $326,000 Before Its Q1 Earnings Release ↗

May 01, 2026

Via The Motley Fool

Pacira (PCRX) Q1 2026 Earnings Call Transcript ↗

April 30, 2026

Via The Motley Fool

Pacira BioSciences Reports First Quarter 2026 Financial Results

April 30, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders

April 28, 2026

From Pacira BioSciences

Via GlobeNewswire

Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty

April 27, 2026

From Pacira BioSciences

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

April 16, 2026

Via Chartmill

Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026

April 16, 2026

From Pacira BioSciences

Via GlobeNewswire

Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens

April 13, 2026

Via MarketMinute

Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures

April 13, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting

March 30, 2026

From Pacira BioSciences

Via GlobeNewswire

Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation

March 11, 2026

From Pacira BioSciences

Via GlobeNewswire

Frequently Asked Questions

Is Pacira BioSciences, Inc. - Common Stock publicly traded?

Yes, Pacira BioSciences, Inc. - Common Stock is publicly traded.

What exchange does Pacira BioSciences, Inc. - Common Stock trade on?

Pacira BioSciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Pacira BioSciences, Inc. - Common Stock?

The ticker symbol for Pacira BioSciences, Inc. - Common Stock is PCRX on the Nasdaq Stock Market

What is the current price of Pacira BioSciences, Inc. - Common Stock?

The current price of Pacira BioSciences, Inc. - Common Stock is 23.09

When was Pacira BioSciences, Inc. - Common Stock last traded?

The last trade of Pacira BioSciences, Inc. - Common Stock was at 06/05/26 01:06 PM ET

What is the market capitalization of Pacira BioSciences, Inc. - Common Stock?

The market capitalization of Pacira BioSciences, Inc. - Common Stock is 1.03B

How many shares of Pacira BioSciences, Inc. - Common Stock are outstanding?

Pacira BioSciences, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.